Crossject
Dijon
About Crossject
Crossject specializes in manufacturing and marketing needleless drug self-injection.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $35.9M
- Funding stage: IPO
- Last round: Post-IPO Debt (Nov 2025)
- Ticker: epa:ALCJ
- Website: crossject.comen
- Phone: +33 (0)3 80 54 98 50
Industries & Categories
Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/crossject-169596 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.